KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Cash (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Change in Cash for 6 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash fell 95.76% year-over-year to $1.4 million, compared with a TTM value of $28.7 million through Sep 2025, up 144.99%, and an annual FY2023 reading of -$9.7 million, up 91.46% over the prior year.
  • Change in Cash was $1.4 million for Q3 2025 at Clover Health Investments, down from $33.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $312.2 million in Q1 2021 and bottomed at -$283.5 million in Q3 2021.
  • Average Change in Cash over 5 years is $10.6 million, with a median of $33.2 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 3634.86% in 2021, while the deepest fall reached 1503.41% in 2021.
  • Year by year, Change in Cash stood at $97.7 million in 2021, then plummeted by 301.28% to -$196.7 million in 2022, then rose by 10.88% to -$175.2 million in 2023, then skyrocketed by 118.94% to $33.2 million in 2024, then crashed by 95.76% to $1.4 million in 2025.
  • Business Quant data shows Change in Cash for CLOV at $1.4 million in Q3 2025, $33.2 million in Q2 2025, and -$39.1 million in Q1 2025.